Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Jun 5, 2025; 16(2): 105801
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105801
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105801
Table 5 Comparison of adverse events to elobixibat by age, n (%)
| < 65 years old | ≥ 65 years old | P value | |
| Adverse events after elobixibat administration of elobixibat | |||
| Abdominal pain | 4 (11.4) | 4 (8.9) | 0.7241 |
| Diarrhea | 4 (11.4) | 4 (8.9) | 0.7241 |
| Total | 8 (22.9) | 8 (17.8) | 0.5869 |
- Citation: Sakai Y, Tsuyuguchi T, Kumagai J, Ohyama H, Kaiho T, Ohtsuka M, Kato N. Efficacy of elobixibat for elderly patients with chronic constipation in a clinic. World J Gastrointest Pharmacol Ther 2025; 16(2): 105801
- URL: https://www.wjgnet.com/2150-5349/full/v16/i2/105801.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i2.105801